Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Diabetes
Sort By
Newest First
1 / 3
Chronic Diseases
Breaking the Cycle of Chronic Disease with New Therapeutic Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-11
Mar 02, 2025
Gene Therapy
Genprex Provides Update on Diabetes Gene Therapy Program
Genprex
PR-02-25-NI-15
Feb 19, 2025
Cold Chain
Managing Temperature-Controlled Logistics for GLP-1 Drugs
Leandro Moreira
Frontier Scientific Solutions
PAO-02-25-CL-02
Feb 05, 2025
Biotechs
Five Small Biotechs to Watch: February 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-01
Feb 03, 2025
Column: New Drug Watch
New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-08
Jun 24, 2022
Diabetes Research
Composition of Gut Microbiome Predicts the Onset of Type 2 Diabetes
University of Turku
PR-M02-22-13
Feb 16, 2022
Digital Therapeutics
Digital Therapeutics: Redefining Prescription Medication in the Information Era
David Kenion
Pharma's Almanac
PAO-05-21-NI-01
May 06, 2021
New $35 Co-Pay Now Available Through Lilly Insulin Value Program in Response to COVID-19 Crisis in U.S.
Eli Lilly and Company
PR-M04-20-NI-010-1621
Apr 07, 2020
Insulin Delivery
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Abbott
PR-M02-20-NI-043
Feb 27, 2020
Update
KalVista Pharmaceuticals Provides Update on Diabetic Macular Edema Programs
KalVista Pharmaceuticals, Inc.
PR-M02-20-NI-011
Feb 11, 2020
Drug Pricing
Lilly Expands Insulin Affordability Options
Eli Lilly and Company
PR-M01-20-NI-028
Jan 17, 2020
Diabetes
Sanofi to Exit Diabetes and Cardiovascular Research
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-19-NI-005
Dec 13, 2019
Drug Approval
Qtrilmet Approved in the EU for the Treatment of Type-2 Diabetes
Nice Insight
PR-M11-19-NI-020
Nov 19, 2019
Diabetes Prevention
Sigrid Therapeutics Takes Another Step Towards a Treatment for Prevention of Type 2 Diabetes
Nice Insight
PR-M10-19-NI-032
Oct 24, 2019
Approval
Farxiga Approved in the US to Reduce the Risk of Hospitalization for Heart Failure in Patients with Type-2 Diabetes
AstraZeneca
PR-M10-19-NI-029
Oct 22, 2019
Drug Delivery
New Capsule Can Orally Deliver Drugs that Usually Have to be Injected
Nice Insight
PR-M10-19-NI-022
Oct 15, 2019
Drug Pricing
Novo Nordisk Launching Additional US Insulin Affordability Offerings in January 2020
Novo Nordisk
PA2138
Sep 11, 2019
M&A
Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes
Vertex
PR-M09-19-NI-008
Sep 04, 2019
Heathcare
Blue Cross and Blue Shield of Minnesota to Cover Insulin Costs at No Charge Next Year
Blue Cross Blue Shield of Minnesota
PR-M08-19-NI-081
Aug 28, 2019
Licensing Agreement
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
Innovent
PR-M08-19-NI-076
Aug 27, 2019
1 / 3
